Digital PCR industry
The digital Polymerase Chain Reaction (PCR) market was a highly competitive market due to increasing incidents of target infectious diseases and genetic disorders across the globe. Additionally, continuous technological advancements in digital PCR technology was also contributing to the growth of the digital PCR industry. The digital PCR’s application in analytical laboratories was steadily increasing before the pandemic. The outbreak has accelerated the growth of the digital PCR industry more than it used to be. Several types of research are going on to prove the accuracy of digital PCR’s for the SARS-CoV-2 virus test, the cause of the COVID-19 pandemic. For instance, the researchers from the Center for Advanced Measurement Science at the National Institute of Metrology in Beijing worked with researchers at the Centers for Disease Prevention and Control of Wuhan and Beijing, and Chongqing University to detect the sensitivity of the digital PCR. The study was aimed at determining whether it was safe to release patients from quarantine that are tested with enhanced featured digital PCR.
The market of digital PCR has grown significantly with the outbreak of COVID-19 which has raised the demand for digital PCR test kits all across the globe. BGI a China-based firm has developed a metagenomic sequencing detection kit which is a 2019-nCoV nucleic acid detection kit- combinatorial Probe-Anchor Synthesis sequencing method to monitor mutations. As the information provided by the company, the metagenomic sequencing kit can identify and diagnose other coronaviruses, including new coronaviruses and respiratory tract infections, and achieve rapid detection of viral sequences. The combination of RT-PCR and metagenomics solution PMseq provided by the company is able to detect known and novel microorganisms, in addition to the COVID-19 virus.
BGI has been working with various authorities in China, including China’s Centre for Disease Control and Prevention and other players in the digital PCR market. For instance, the company together with China’s authority is delivering detection kits to various hospitals and local disease control centers in China. The company is considered as the third-party collaborator which got its authorization by China’s National Health Commission in detecting the Covid-19 virus in China. Further, the company is also engaged with other relevant organizations present outside China to supply the test kits. The company also offers additional pathogen detection solutions using next-generation sequencing technology in combination with test kits to its consumers. International delivery has also been started by the company. In order to make test kits easier to use the kits are equipped with English manuals. The company also offers online training programs to laboratories on how to use the kit most effectively. The test Kits are currently being distributed in more than 50 countries and regions across the globe making the digital PCR market growth considerably high.
OMR Global Recently Published Report on: https://www.omrglobal.com/industry-reports/impact-of-covid-19-on-global-digital-pcr-industry
The Report Covers
- Comprehensive research methodology of the global dPCR and qPCR Industry.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global dPCR and qPCR Industry.
- Insights about market determinants that are stimulating the global Digital dPCR and qPCR Industry.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Market Segmentation
By Technology
- Quantitative PCR (qPCR)
- Digital PCR (dPCR)
By Product
- Instruments
- Reagents & Consumables
- Software & Services
To Learn More About this Report Request a Free Sample Copy @ https://www.omrglobal.com/request-sample/impact-of-covid-19-on-global-digital-pcr-industry
